Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1
Top Cited Papers
- 9 December 2008
- journal article
- research article
- Published by Hindawi Limited in Human Mutation
- Vol. 30 (3), 379-390
- https://doi.org/10.1002/humu.20868
Abstract
Fibrodysplasia ossificans progressiva (FOP) is an autosomal dominant human disorder of bone formation that causes developmental skeletal defects and extensive debilitating bone formation within soft connective tissues (heterotopic ossification) during childhood. All patients with classic clinical features of FOP (great toe malformations and progressive heterotopic ossification) have previously been found to carry the same heterozygous mutation (c.617G>A; p.R206H) in the glycine and serine residue (GS) activation domain of activin A type I receptor/activin‐like kinase 2 (ACVR1/ALK2), a bone morphogenetic protein (BMP) type I receptor. Among patients with FOP‐like heterotopic ossification and/or toe malformations, we identified patients with clinical features unusual for FOP. These atypical FOP patients form two classes: FOP‐plus (classic defining features of FOP plus one or more atypical features) and FOP variants (major variations in one or both of the two classic defining features of FOP). All patients examined have heterozygous ACVR1 missense mutations in conserved amino acids. While the recurrent c.617G>A; p.R206H mutation was found in all cases of classic FOP and most cases of FOP‐plus, novel ACVR1 mutations occur in the FOP variants and two cases of FOP‐plus. Protein structure homology modeling predicts that each of the amino acid substitutions activates the ACVR1 protein to enhance receptor signaling. We observed genotype‐phenotype correlation between some ACVR1 mutations and the age of onset of heterotopic ossification or on embryonic skeletal development. Hum Mutat 0, 1–12, 2008.Keywords
Funding Information
- Center for Research in FOP and Related Disorders
- International FOP Association
- Ian Cali Endowment
- Weldon Family Endowment
- Isaac and Rose Nassau Professorship of Orthopaedic Molecular Medicine
- Rita Allen Foundation
- National Institutes of Health (R01-AR41916)
This publication has 75 references indexed in Scilit:
- Dysregulated BMP Signaling and Enhanced Osteogenic Differentiation of Connective Tissue Progenitor Cells From Patients With Fibrodysplasia Ossificans Progressiva (FOP)Journal of Bone and Mineral Research, 2008
- Mutations in BMP4 Cause Eye, Brain, and Digit Developmental Anomalies: Overlap between the BMP4 and Hedgehog Signaling PathwaysAmerican Journal of Human Genetics, 2008
- Cyclic dermal BMP signalling regulates stem cell activation during hair regenerationNature, 2008
- Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolismNature Chemical Biology, 2007
- Endocrine Regulation of Energy Metabolism by the SkeletonCell, 2007
- A New Subtype of Brachydactyly Type B Caused by Point Mutations in the Bone Morphogenetic Protein Antagonist NOGGINAmerican Journal of Human Genetics, 2007
- Loss of a quiescent niche but not follicle stem cells in the absence of bone morphogenetic protein signalingProceedings of the National Academy of Sciences of the United States of America, 2007
- Noggin regulates Bmp4 activity during pituitary inductionDevelopmental Biology, 2007
- Bone Morphogenetic ProteinsGrowth Factors, 2004
- The TGFβ Receptor Activation Process: An Inhibitor- to Substrate-Binding SwitchMolecular Cell, 2001